Ocular Therapeutix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	737.06	392.1	195.81	102.3	164.16
Cash & Short-Term Investments	737.06	392.1	195.81	102.3	164.16
Cash Growth	87.98%	100.25%	91.41%	-37.68%	-28.02%
Accounts Receivable	30.65	32.39	26.18	21.33	21.14
Other Receivables	-	0.18	-	-	-
Receivables	30.65	32.56	26.18	21.33	21.14
Inventory	3.56	3.04	2.31	1.97	1.25
Prepaid Expenses	10.86	13.28	7.79	4.03	4.75
Restricted Cash	-	-	0.15	-	-
Total Current Assets	782.13	440.99	232.24	129.63	191.3
Property, Plant & Equipment	24.31	15.33	18.21	17.9	11.82
Other Long-Term Assets	1.61	1.61	1.61	1.76	1.76
Total Assets	808.06	457.94	252.06	149.29	204.89
Accounts Payable	4.15	4.18	4.39	5.12	4.59
Accrued Expenses	43.84	35.12	28.67	24.1	20.12
Current Portion of Leases	2.82	1.93	1.59	1.6	1.62
Current Unearned Revenue	-	0.13	0.26	0.58	-
Total Current Liabilities	50.81	41.35	34.9	31.4	26.34
Long-Term Debt	71.34	68.51	74.93	54.01	51.44
Long-Term Leases	2.82	5.35	6.88	8.68	5.92
Long-Term Unearned Revenue	14	14	14.14	13.39	13
Other Long-Term Liabilities	14.79	13.39	30.1	6.44	20.19
Total Liabilities	153.75	142.59	160.93	113.91	116.89
Common Stock	0.02	0.02	0.01	0.01	0.01
Additional Paid-In Capital	1,811	1,206	788.7	652.21	633.8
Retained Earnings	-1,157	-891.08	-697.58	-616.84	-545.8
Shareholders' Equity	654.31	315.34	91.13	35.38	88
Total Liabilities & Equity	808.06	457.94	252.06	149.29	204.89
Total Debt	76.97	75.78	83.39	64.28	58.98
Net Cash (Debt)	660.09	316.32	112.42	38.02	105.18
Net Cash Growth	108.68%	181.38%	195.70%	-63.86%	-37.99%
Net Cash Per Share	3.53	2.00	1.31	0.46	1.28
Filing Date Shares Outstanding	217.69	159.02	148.63	77.51	76.75
Total Common Shares Outstanding	215.93	157.75	114.96	77.2	76.73
Working Capital	731.32	399.63	197.34	98.23	164.96
Book Value Per Share	3.03	2.00	0.79	0.46	1.15
Tangible Book Value	654.31	315.34	91.13	35.38	88
Tangible Book Value Per Share	3.03	2.00	0.79	0.46	1.15
Machinery	21.33	18.05	16.78	13.75	12.28
Construction In Progress	10.26	0.12	0.28	4.07	0.58
Leasehold Improvements	15.28	14.53	14.7	9.07	9.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.